These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21304243)

  • 41. Treatment of recalcitrant plantar warts with imiquimod.
    Yesudian PD; Parslew RA
    J Dermatolog Treat; 2002 Mar; 13(1):31-3. PubMed ID: 12006136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
    Alomar A; Bichel J; McRae S
    Br J Dermatol; 2007 Jul; 157(1):133-41. PubMed ID: 17501955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDA approval of imiquimod cream in treatment of STD warts.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377-8. PubMed ID: 11361830
    [No Abstract]   [Full Text] [Related]  

  • 46. Genital Vitiligo-like Hypopigmentation After Treatment With 5% Imiquimod.
    García-Montero P; Repiso Jiménez JB; Fernández Morano MT; de Troya Martín M
    Actas Dermosifiliogr; 2017 May; 108(4):378-380. PubMed ID: 27912903
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
    Burnett TJ; English JC; Ferris LK
    J Drugs Dermatol; 2010 Aug; 9(8):1022-4. PubMed ID: 20684157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of topical 5% imiquimod during pregnancy: a case series.
    Einarson A; Costei A; Kalra S; Rouleau M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
    [No Abstract]   [Full Text] [Related]  

  • 49. The efficacy of imiquimod 5% cream (Aldara® in the treatment of aural plaque in horses: a pilot open-label clinical trial.
    Torres SM; Malone ED; White SD; Koch SN; Watson JL
    Vet Dermatol; 2010 Oct; 21(5):503-9. PubMed ID: 20500494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of combination therapy of oral zinc sulfate with imiquimod, podophyllin or cryotherapy in the treatment of vulvar warts.
    Akhavan S; Mohammadi SR; Modarres Gillani M; Mousavi AS; Shirazi M
    J Obstet Gynaecol Res; 2014 Oct; 40(10):2110-3. PubMed ID: 25132143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune response modification: imiquimod.
    Tyring S
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S11-3. PubMed ID: 9842095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imiquimod: potential risk of an immunostimulant.
    Benson E
    Australas J Dermatol; 2004 May; 45(2):123-4. PubMed ID: 15068461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Off-label indications for imiquimod.
    Ganjian S; Ourian AJ; Shamtoub G; Wu JJ; Murase JE
    Dermatol Online J; 2009 May; 15(5):4. PubMed ID: 19624982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Warts treatment.
    Treat Rev; 1995 Nov; (no 20):7. PubMed ID: 11363030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
    Quist SR; Gollnick HP
    Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream.
    Agarwal S; Berth-Jones J
    Br J Dermatol; 2002 Feb; 146(2):338-9. PubMed ID: 11903259
    [No Abstract]   [Full Text] [Related]  

  • 59. Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients.
    Trakatelli M; Katsanos G; Ulrich C; Kalabalikis D; Sotiriadis D; Stockfleth E
    Int J Immunopathol Pharmacol; 2010; 23(2):387-96. PubMed ID: 20646334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
    Brady S; Wilson JD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):314-7. PubMed ID: 15096142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.